NSE · EPIGRAL
Epigral Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹705 Cr with net profit ₹99 Cr — a 14.06% net margin, versus 13.06% the period before.
Shareholding
As of 2026-06-30
- Promoter68.83%
- Public24.58%
- FII1.03%
- DII5.56%
76,305 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.24× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #34 of 159 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹2,02,426 Cr | 101.65 | 32.25 | 26.72% | 17.54% |
| Pidilite Industries Ltd. | ₹1,59,705 Cr | 60.3 | 14.74 | 22.61% | 17.2% |
| SRF Ltd. | ₹74,669 Cr | 33.32 | 5.32 | 13.07% | 13.01% |
| Linde India Limited | ₹53,111 Cr | 97.2 | 12.45 | 12.87% | 20.59% |
| Gujarat Fluorochemicals Ltd. | ₹52,578 Cr | 85.12 | 6.73 | 7.13% | 11.41% |
| Navin Fluorine International Ltd. | ₹44,646 Cr | 56.14 | 11.23 | 16.69% | 21.73% |
| Godrej Industries Ltd. | ₹37,805 Cr | 30.9 | 3.38 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹33,491 Cr | 41.9 | 7.12 | 15.96% | 16.07% |
| Deepak Nitrite Ltd. | ₹22,448 Cr | 28.34 | 3.85 | 9.43% | 9.13% |
| Aether Industries Limited | ₹21,771 Cr | 90.72 | 8.86 | 8.94% | 19.11% |
| Epigral Limited(this company) | ₹4,960 Cr | 18.3 | 2.23 | 14.94% | 10.32% |
AI analysis
AI-generated · google/gemini-2.5-flashEpigral Limited, trading as EPIGRAL, has a market capitalization of Rs 4673 Cr. The company reported revenue of Rs 2542.16 Cr and a profit margin of 13.14%. Its earnings per share (EPS) stood at Rs 76.38, with a return on equity (ROE) of 14.94% and return on capital employed (ROCE) of 14.69%. The debt-to-equity ratio was 0.28.
Positives
- +The debt-to-equity ratio is low at 0.28.
- +The promoter holding is substantial at 68.8285%.
- +There are no promoter shares pledged (0%).
- +The company is not under surveillance.
Negatives
- −Revenue growth for the annual period ending March 2026 was negative at -0.9%.
- −Promoter holding has decreased from 71.1805% in March 2022 to 68.8285% in June 2026.
- −FII holdings have decreased from 1.1457% in December 2022 to 1.0341% in June 2026.
- −The dividend yield is unspecified at 46%, making assessment difficult.
Financial Performance
Epigral Limited reported annual revenue of Rs 2542.16 Cr as of March 2026. The revenue growth stood at -0.9%. The net profit for the same period was Rs 331.97 Cr. The company's EPS was Rs 76.38 for the period ending March 2026.
Profitability & Returns
The company recorded a profit margin of 13.14%. Return on equity (ROE) for Epigral Limited was 14.94%, and return on capital employed (ROCE) was 14.69%. The earnings per share (EPS) were Rs 76.38.
Balance Sheet
Epigral Limited maintained a debt-to-equity ratio of 0.28, indicating a low level of debt relative to equity. The book value per share was Rs 514.92.
Ownership & Pledges
As of June 30, 2026, promoter holding in Epigral Limited was 68.8285%. Domestic Institutional Investors (DII) held 5.5596%, while Foreign Institutional Investors (FII) held 1.0341%. Public shareholding was 24.5778%. There were no promoter pledges reported (0%).
Regulatory & Surveillance
The company is not currently under any surveillance measure.
Data as of — price: 2026-09-10 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.